Pathways to Participation: Breaking Down Barriers to Clinical Trials in Marginalized and Rural Communities

Thank you for participating in our survey on barriers to clinical trial participation for underrepresented communities. Your insights will help improve access to clinical trials and ensure they are inclusive of all communities.
1.Age
2.Gender Identity
3.Ethnicity/Race
4.Geographic Location
5.Healthcare Coverage Status
6.When you hear about clinical trials, what is the first thing that comes to mind?
7.If yes, what factors influenced your decision to participate or not participate?
8.What do you see as the biggest barriers to clinical trial participation for you or your community? (Select all that apply)
9.How familiar are you with clinical trials related to liver diseases such as..?
Very Familiar
Somewhat Familiar
Not Familiar at All
MASLD
MASH
Viral Hepatitis
10.Are you aware of clinical trials focused on conditions such as liver cancer, viral hepatitis, or mental health and substance use disorders (like opioid use disorder)?
11.If not, what is the best way to share information about these trials with you or your community? (Select all that apply)
12.If you have co-existing conditions like diabetes, hypertension, or cardiovascular disease, how do these impact your ability to participate in a liver disease clinical trial?
13.For participants living in rural or underserved communities, what additional challenges do you face when it comes to participating in clinical trials? (Select all that apply)
14.What improvements could be made to make clinical trials more accessible to rural and underserved communities?
15.How much do you agree with the following statement: “I trust that clinical trials are conducted with the best interest of my community in mind”?
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree
16.What could researchers or healthcare providers do to build trust with your community and encourage more participation in clinical trials?
17.What logistical challenges would prevent you from participating in a clinical trial? (Select all that apply)
18.How do socioeconomic challenges, such as financial concerns or lack of insurance coverage, impact your ability to participate in clinical trials?
19.· Q15: What additional suggestions do you have for making clinical trials more accessible and inclusive for underrepresented communities?
Thank you for completing our survey. Your responses will help us create strategies to make clinical trials more accessible to everyone, regardless of background or location.
You will receive your $10 gift card via email within the coming days as a token of our appreciation for your participation.